Marketable Securities, Current in USD of Terns Pharmaceuticals, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Terns Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2025.
  • Terns Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $145M, a 41.2% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Terns Pharmaceuticals, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $145M +$42.3M +41.2% Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $169M +$35.7M +26.7% Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $195M +$19.7M +11.2% Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $197M +$13.2M +7.2% Dec 31, 2024 10-Q 2025-11-10
Q3 2024 $103M -$126M -55.1% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $134M -$70.9M -34.6% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $176M +$62.4M +55.1% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $184M +$43.6M +31.2% Dec 31, 2023 10-K 2025-03-20
Q3 2023 $229M +$104M +84% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $205M +$81.7M +66.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $113M +$5.78M +5.39% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $140M +$21.6M +18.3% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $124M +$11.9M +10.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $123M +$5.51M +4.69% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $107M +$10.6M +11% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $118M +$118M Dec 31, 2021 10-K 2023-03-27
Q3 2021 $112M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $117M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $96.8M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.